Doxorubicin Hydrochloride Injection, Powder, Lyophilized, For Solution
Product Images NDC 0143-9092

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 0143-9092). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Doxorubicin HCl For Injection Usp 1)

Chemical structure diagram of Doxorubicin Hydrochloride showing atoms and bonds, along with the molecular formula C27H29NO11•HCl and molecular weight of 579.99.*

FDA Label Image

Fig. 1 (Doxorubicin HCl For Injection Usp 2)

A meta-analysis chart showing disease-free survival hazard ratios from six studies comparing Doxorubicin-based treatment to CMF. The chart plots hazard ratios with 95% confidence intervals for each trial, indicating whether Doxorubicin is better or worse than CMF for disease-free survival, including a combined estimate represented by a diamond.*

FDA Label Image

Fig. 2 (Doxorubicin HCl For Injection Usp 3)

A forest plot titled 'Meta-analysis of Overall Survival' comparing hazard ratios with 95% confidence intervals for multiple trials, including NSABP B-15, SECSG 2, ONCOFRANCE, SE Sweden BCG A, NSABC Israel Br0283, and Austrian BCSG 3. The plot compares outcomes of Doxorubicin-based treatments versus CMF, with a diamond shape summarizing results for six studies labeled 'Doxo based.' The x-axis ranges from 0 to 2, indicating whether Doxorubicin is better or worse than CMF.*

FDA Label Image

10 mg Vial (Doxorubicin HCl For Injection Usp 4)

Label for Doxorubicin Hydrochloride Injection, USP, 10 mg per vial, lyophilized powder for solution. The label states it is for intravenous use only and single-dose vial. It includes storage instructions and warnings regarding extravasation risks. Distributed by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

50 mg Vial (Doxorubicin HCl For Injection Usp 5)

Label for Doxorubicin Hydrochloride injection, USP powder, lyophilized for solution, 50 mg per vial. It is intended for intravenous use only and is a single-dose vial. Manufactured by Thymoorgan Pharmazie GmbH, Germany, and distributed by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Representative Carton Serialization Image (Doxorubicin HCl For Injection Usp 6)

Label panel for Doxorubicin Hydrochloride injection, powder, lyophilized, for solution, showing a 2 mg/mL strength. The label features a datamatrix barcode, lot number, expiration date, GTIN, and serial number. The labeler is Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Representative Carton Serialization Image (Doxorubicin HCl For Injection Usp 7)

A label panel showing product identification details for Doxorubicin Hydrochloride injection powder, lyophilized, for solution, 2 mg/mL strength. The label includes a QR code, GTIN number, serial number (SN), expiration date (EXP), and lot number (LOT). The label is from Hikma Pharmaceuticals USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.